Objective: the present study was designed to compare the bone mineral density of children and adolescents with celiac disease to the bone mineral density of controls, and to evaluate laboratory analysis of calcium metabolism of celiac disease patients.
Introduction
Osteoporosis is a metabolic bone disease, characterized by low bone mineral density (BMD). Increases in life expectancy mean that osteoporosis is now considered a public health problem because of the greater susceptibility to fractures which ensues. Tracking groups at risk from low BMD is, therefore, an extremely important procedure in order to adequately treat them. 1 Patients with celiac disease (CD) present an elevated incidence of peripheral skeleton bone fractures. 2, 3 Adults with CD have an increased risk of reduced BMD. [4] [5] [6] [7] [8] [9] [10] [11] [12] [13] [14] [15] [16] [17] [18] [19] [20] Data relating to the BMD of children and adolescents with CD are, however scarce. [21] [22] [23] [24] [25] [26] [27] [28] [29] Certain studies of patients within the pediatric age group demonstrate that a gluten-free diet promotes an increase in BMD. 21, 22, [24] [25] [26] [27] [28] However, it is still debatable whether BMD is completely recovered with dietary therapy. 23, 26, 29 Peak bone mass is reached by the end of adolescence, 30, 31 which emphasizes the importance of studying bone mineral content during childhood and adolescence.
Of the numerous techniques which have been developed, Dual Energy X-ray Absorptiometry (DEXA) is the most appropriate for the analysis of BMD as it makes possible a rapid analysis which is highly reproducible and very precise, of the status of bone mineral density whilst employing a very low radiation dosage. 1 This study was performed with the objective of comparing the BMD of children and adolescents with CD on a gluten-free diet with that of healthy controls and also to evaluate laboratory tests relating to calcium metabolism for the CD patients.
Patients and methods
Patients This is a cross-sectional study in which 30 patients were assessed. Of these 17 were children and 13 adolescents and 17 were female. All had been diagnosed with CD in accordance with the recommendations of the European Society of Paediatric Gastroenterology Hepatology and Nutrition (ESPGHAN). 32, 33 The children's ages varied from 6 to 9 years, and the adolescents' from 13 to 16 years.
Sample size was calculated using the program Jandel SigmaStat version 2.0. Data was based upon the comparison of the results for BMD of the first six adolescent patients and the first six adolescent controls. The difference between the averages was 0.120 g/cm 2 , giving a standard deviation of 0.09. When the power of the test was set at 0.80 and alpha at 0.05, sample size was estimated at 10 patients per group.
The patients were selected consecutively according to date of consultation and based upon adherence to the gluten-free diet for at least a year, as revealed by nutritional interview. At the time of the study, all of the patients were asymptomatic, with small intestine biopsies showing preserved villous architecture with no increases in intraepithelial lymphocytes. None of the patients were receiving supplements of calcium, vitamin D, estrogen, corticoids or anticonvulsants.
Controls
A control group of 23 individuals was assessed. Twelve children were compared with the patient group, according to sex and age (plus or minus 6 months), and 11 adolescents between 13 and 16 years old were compared with the patient group, according to sex, pubertal stage and time of menarche. The control group was made up of healthy individuals who routinely attended the Pediatric Clinic or the Adolescents Clinic at the Hospital São Paulo. This group of patients underwent anamnesis and detailed physical examination which returned no signs or symptoms indicative of chronic disease and/or gastrointestinal disease. Other conditions were also ruled out before these patients were included in the control group, they were: the practice of physical exercise (excessive) for more than 10 hours a week, the use of nay type of medication, use of hormones, vitamins or calcium supplements. The children had ratios for weight for height and height for age, which were within 2 Z scores of the growth curves of the National Center for Health Statistics (NCHS). Adolescents had a body mass index which was between 15% and 85% and a stature for age ratio which was within 2 Z scores of the NCHS value. 34 The parents or guardians of the patients and the controls signed an informed consent form and the study was approved by the Ethics Committee of the Universidade Federal de São Paulo -Escola Paulista de Medicina.
Methods
All of the patients and the controls were assessed for weight and height. In order to obtain body weight, a set of platform scales made by Filizola, with gradations every 100 grams, recalibrated after each use. For height measurement, a fixed taximeter, accurate to 0.5 cm, was used.
Bone mineral density, in g/cm 2 , was evaluated for all patients and controls by DEXA (DPX-Lunar; Lunar Radiation Corp, Madison, WI), and all examinations were performed by the same operator.
In order to assess digestive absorption function, the patients were tested for D-xylose absorption (blood) 35 and fecal fat levels were determined using the van de Kamer method. 36 The D-xylose absorption test consisted of the oral administration, to a fasting patient, of 15 g/m 2 of this pentose, up to a maximum of 25 g, diluted at 10%, testing serum levels after an hour. Fecal fat determination by the van de Kamer method consists of the collection of feces for 72 hours after a six-day diet including a minimum of 1 g/Kg more than the normal diet. Fecal fat is determined after the sample has been homogenized. Patients were also tested for serum levels of total calcium, ionized calcium, phosphorous, magnesium, alkaline phosphatase and parathormone.
Statistical analysis
The Student t test for two samples was used to compare the weight and height of the group of CD patients with the controls. Analysis of variance was used to compare patient and control BMD. Fisher's test was used to assess what proportion of the adolescents had begun a gluten-free diet after two years of age. Table 1 contains mean averages for age, weight, height and BMD for controls and patients. Statistically significant differences (p = 0.015) were observed for BMD between adolescent patients and adolescent controls. There was no statistically significant difference between child patients and child controls (p = 0.595).
Results
Serum levels of total calcium, ionized calcium, alkaline phosphatase and parathormone were normal in all patients analyzed. Phosphorous levels were below the reference value in seven patients (23.3%) of which four were adolescents and three children, and in one of these patients (a child) the level of magnesium was also below normal limits.
The results for D-xylose absorption in blood and fecal fat content by the van de Kamer method were within normal limits for all patients.
When the age at which gluten-free diet was started was analyzed (Table 2) , it was observed that the proportion of adolescents who had started their gluten-free diet after they were 2 years old was greater than that of the group of children (p < 0.001).
Discussion
The mechanism by which bone is lost in CD appears to be related to calcium malabsorption which resultant secondary hyperparathyroidism. The increased parathormone secretion accelerates cortical bone loss. Vitamin D malabsorption also contributes to reduced BMD, although it is a factor of lesser importance Other factors which cause reduced BMD are: reduced calcium consumption, lack of physical activity, reduced levels of sexual hormones, trace element and magnesium deficiencies and effects which are deleterious to the liberation of cytokines by an inflamed intestine. 37, 38 The large scale increase in bone which is observed during early childhood is not only determined by longitudinal growth of bones, but also by the positive relationship between the apposition of bone tissue onto the periosteal surface and its endosteal re-absorption. This progressive mineralization occurs primarily during the first two years of life and during adolescence. The age at which peak bone mass is achieved remains the subject of disagreements. Nevertheless, studies agree that the great majority of bone mass is accrued by the end of adolescence. 30, 31 The importance of this phase of life to the establishment of sufficient peak bone mass leads to the supposition that osteoporosis is a disease with origins at pediatric ages which manifests in adult life. This being the case, the study of bone mineralization during childhood and adolescence has come to be considered as relevant to osteoporosis prevention.
Even though a gluten-free diet results in coeliac disease patients achieving increased intestinal absorption of calcium, disturbances to bone metabolism can persist and impede complete recovery of bone mineral density. In this study, values for weight, height and BMD were all lower among the adolescents with CD on gluten-free diet than they were for the controls. De Lorenzo et al. 26 also observed reduced anthropometric indices and BMD values in adolescents after 1 year of a gluten-free diet. Leiva et al. 23 demonstrated that CD patients presented lower bone mass than did controls despite early diagnosis and adherence to the gluten-free diet, although they didn't distinguish between the group of children and the group of adolescents. Kalayci et al. 29 found that a year of a gluten-free diet promoted increases in BMD, however, these values were well below normality.
A number of studies of adult populations have also observed that a gluten-free diet did not completely restore BMD. [4] [5] [6] [7] [8] [9] 12, [18] [19] [20] This study showed that all of the adolescents had been more than two years old when their gluten-free diet was begun, while a minority of the children started their diets after they were two. This fact emphasizes the importance of early diagnosis and treatment to the prevention of bone disturbances. Scotta et al. 25 observed that the BMD of CD patients, without distinguishing between the group of children and that of adolescents, that those whose gluten free diet had begun after they were two years old were smaller than those who had started the diet before this age. McFarlane et al. 7 attributed the low BMD levels observed in adults with CD on gluten-free diet to late diagnosis and the consequential failure to achieve maximum bone mass. Valdimarson et al. 13 demonstrated that adults' BMD remained low after 3 years on a glutenfree diet and suggested that calcium malabsorption over a prolonged period and secondary hyperparathyroidism can cause irreversible osteoporosis. The authors recommend that patients with elevate parathormone at the time of CD diagnosis should receive more careful observation. In this study, levels of parathormone and of both total and ionized calcium were all within normal limits in CD patients on gluten-free diets.
In conclusion, the bone mineral density of adolescents with CD who were on gluten-free diet was lower than it was for controls, however, children with CD did not present any difference in BMD when compared with controls. This being so, osteoporosis tracking by means of BMD assessment has proved itself useful, especially with adolescent with CD with nutritional complaints and who began dietary therapy after they were two years old. Table 2 -Distribution of children and adolescents with celiac disease according to age at the beginning of the gluten-free diet
Fisher's test < 0.001.
